Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial

C Burrows1, J M P Holly, N J Laurence

  • 1Department of Clinical Sciences at North Bristol, IGFs and Metabolic Endocrinology Group, University of Bristol, The Medical School, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, United Kingdom.

Endocrinology
|April 15, 2006
PubMed

Insights

Insulin-like growth factor-binding protein 3 (IGFBP-3) exhibits dual actions on breast epithelial cells. Its effects on cell growth and survival depend on cholesterol-stabilized integrin receptor complexes and fibronectin presence.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Insulin-like growth factor-binding protein 3 (IGFBP-3) is typically viewed as counteracting IGF actions and is explored for cancer therapy.
  • However, elevated IGFBP-3 levels in breast tumors correlate with aggressive disease and poor prognosis.
  • This suggests context-dependent roles for IGFBP-3 in breast cancer progression.

Purpose of the Study:

  • To investigate the factors determining whether IGFBP-3 exerts positive or negative effects on breast epithelial cells.
  • To elucidate the mechanisms underlying IGFBP-3's differential actions in various cellular contexts.

Main Methods:

  • Utilized three breast epithelial cell lines (Hs578T, MCF-7, MCF-10A) cultured on different extracellular matrix components (collagen, laminin, fibronectin).
  • Assessed cell attachment, apoptosis, growth, and survival under various conditions, including treatment with IGFBP-3, a serine phosphorylation domain peptide, IGF-I, MAPK inhibitors, and beta1-integrin antibodies.
  • Investigated molecular interactions of IGFBP-3 with caveolin-1, beta1-integrins, focal adhesion kinase, and MAPK signaling pathways.

Main Results:

  • IGFBP-3 promoted attachment and survival of Hs578T cells on fibronectin, contrasting its effects on collagen/laminin.
  • IGFBP-3's pro-survival effects on Hs578T and MCF-7 cells were linked to beta1-integrin, MAPK signaling, and cholesterol-stabilized complexes.
  • IGFBP-3 promoted growth and survival in nonmalignant MCF-10A cells, but these effects were context-dependent, being reversed by fibronectin, beta1-integrin blockade, or disruption of cholesterol-stabilized complexes.
  • On Hs578T cells, IGFBP-3 bound to caveolin-1 and beta1-integrins, promoting aggregation and activating MAPK signaling.

Conclusions:

  • IGFBP-3 exhibits context-dependent actions on breast epithelial cells, influencing growth and survival.
  • The status of cholesterol-stabilized integrin receptor complexes and the extracellular matrix component fibronectin are critical determinants of IGFBP-3's effects.
  • These findings highlight the complex role of IGFBP-3 in breast cancer and suggest therapeutic strategies targeting these molecular interactions.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...